---

Advertising Information | FAQs | About Us | Contact Us | Privacy Policy

---

---

If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.

Posted in 2009:

• Will Pharma Spend More on eMarketing than on TV Ad...
• Pharmacos Spend More on DTC Advertising When There...
• Did State Medicaid Programs Finance Plavix Direct-...
• Reminder DTC Ads OK in Canada, Not in US. What's U...
• New Poll Reveals that Cialis & Levitra Brand Marke...
• It's Advertising Awards Season Again! MM&M Beware ...
• FDA Approves Depressant Drug For The Annoyingly Ch...
• Alli's New Marketing Strategy: Enhance Product Cla...
• Marketing Team Players Should Pay Attention to the "e" in "Team": Ethics
• Pharma, Freedom of Speech, and Ad Agencies
• The New York Times, DTC, and Me
• Pharma Marketers are Salivating in Anticipation of Mental Health "Epidemic"
• Will Latisse Turn Brooke Shields' Blue Eyes Brown?
• Pristiq DTC Campaign Challenged to Concisely Communicate Risk
• The DTC Media Machine is Struggling
• Weight Loss Drug Alli on Life Support. GSK Picks New Agency to Oversee Its Eventual Death
• GSK, Sharing Miracles, Celebrities: Where's the Transparency?
• OMG! Worst Print Ad Ever! Plus: Is that French Actor Vincent Lindon?
• Should the Tax Deduction for DTC Advertising Expenses be Eliminated?
• Novo Nordisk's Branded (Levemir) Tweet is Sleazy Twitter Spam!
• Nasonex Bee May Usher In a Whole New Way to do FDA-friendly Pharma Tweets
• Do Pharma Marketers Encourage Consumers to Self-Diagnose?
• Marketing Mix of Leading Pharma Advertisers in 2008
• What Pharma Should NOT Learn from P&G and Pringles
• If DTC Ads were Allowed in Picadilly Circus
• All Surveys Point to a Further Decrease in DTC Spending This Year
• Andy Behrman, Now an Anti-BMS Spokesperson, Says "Ask Your Doctor If Abilify is Wrong for You"
• Behrman Wasn't the First Patient Spokesperson Paid Big Bucks By BMS
• Arnold Friede Blasts FDA's Right to Define "Reasonable Man" Without External Input
• If Off-label Use of Anti Swine Flu Drugs are OK, Why Aren't Reminder Ads that Lack Fair Balance Also OK?
• Gardasil Sales: One $ Less (out of three)
• Cialis Ads Make a Splash, But Sales are Down
• Botox: Medicine's Answer to Duct Tape
• Overactive Bladder: "Pharmacia instrumental in creating new disease" says Former VP
• Detrol v. Toviaz: Marketing Replaces Innovation at Pfizer!
• Did I Miss the Fair Balance in Last Night's Omnaris Nasal Spray TV Commercial?
• Update on that YAZ YouTube Video
• DTC Ad Spending Decreased 18% in 2008. Worse Than Expected!
• Who Are the "Anti-DTC" Bloggers? This Blogger Wants to Know
• Do Fat People Like Wynonna Judd's Music? GSK and alli May Think They Do.
• Botox v. Reloxin: Market Share Battle May Revive DTC Spending Late in 2009
• Rooster and Friends Win Pharm Exec Ad Stars Award
• Get a DTC Check Up!
• Economy Down, Insomnia & Depression Up. Result: Less Ads Needed to Sell More Drugs?
• Mr. Mucus Turns Bigger and Badder
• You Must Score Better than 84% on Viagra's Sexual Health Quiz to NOT Have Signs of ED
• Viagra Print Ad Art Imitates Life as it Could be Without FDA Regulations
• Drug Fact Box: It All Depends on What You Mean by "Fact"
• An Avodart Print Ad that FDA Missed
• FDA Warns GSK About Enlarged Avodart Ad Imagery
• Where's Da Wabbit (Abe and Beaver too)?
• My 2009 DTC Ad Spending Prediction is Now Conventional Wisdom
• BMS's "Oh, Yes I Can!" Ad is Reminescent of Obama's "Yes We Can!" Slogan
• YAZ Commercial Yanked from TV, But Not from YouTube
• Let's Focus on Effectiveness, Not Dollars Spent as a Measure of DTC Success
• Was a Rat Harmed in the Filming of This Pfizer Commercial?
• DTC Spending Will Be Decimated in 2009, Experts Say
• Adherence Programs: Start by Understanding Patients
• The Secret Lives of DTC Critters
• Will Obama Eliminate the Advertising Business-Tax Deduction to Cover His Bailout Nut?
• Country Music Superstar Judds Corner the Pharma Celebrity Market!
• Wolf(e) at DTC Piggy's Door Huffing and Puffing
• Free Health Speech - Marketers, Reach for Your Gun!

Posted in 2008:

• Revised DTC Guidelines Do Little to Appease Legislators
• New PhRMA DTC Guidelines Ignore Elephant in Room: Moratorium
• Ad Spending: "Worst is yet to come"
• Lilly's Cialis Campaign Wins "Marketing Overdose Award"
• New Rozerem Print Ad Takes Cue from Pepsi Marketers
• Pharma Marketing: 1967 vs. 2007
• What's the Future of DTC Advertising?
• Scare Balance or Scare Tactics? A Weak Case Against More DTC Risk Information
• DTC Ad Spending Will Decrease 9% in 2008 and 11% in 2009!
• An Experiment: Ban All DTC Broadcast Advertising for One Year
• Allergan Doesn't Comply with PhRMA Guidelines, Wins Kudos Anyway
• Merck's Goal: "One Less" Gardasil Marketing Problem
• FDA and YAZ: Is FDA Helping Marketers Work Around Regulations?
• DTC Pundit Throws in Political Towel
• Boston Legal's Denny Crane Takes on Pharma Marketing. Where does he get his "facts?"
• Drug Ads from the Doctor's Perspective
• Pfizer Saves $1,349,432.90 on New Lipitor Ads!
• Introducing the Politically Incorrect AmbienCR Rooster
• Rethinking the Value of DTC Advertising
• FDA Intern Learns All About the "Affect Misattribution Procedure"
• OOH! Narrowcast DTC Advertising
• Praise for Lyrica Ad: Is This a Joke?
• Lyrica Lightens Up, DTCwise
• Will Viagra be Approved for Antidepressant-Related Sexual Dysfunction in Women?
• Pharma DTC Ads Portray Women as Weak and Battered Victims
• Can a Moratorium-delayed DTC Ad Refer to a Drug as "New"?
• Battered Woman Imagery in Pfizer's New Fibromyalgia Ad
• Viagra Induces Major-League Wood!
• Bad News About "Good" Cholesterol Adds to Need for DTC Education
• Pharma Marketers Sometimes View Patients Merely as Symptoms to be Treated
• 40over40: Lilly's DTC ED Awareness Campaign in the UK
• Professional Advertising Doing Well. DTC? Not So Much
• FDA DTC Review: The House that Troy Built
• Ruth Day and the Bees Repeat Performance at House DTC Hearing
• DTC Marketers Heading for Skid Row!
• Chantix Road Rage - Revisited
• Zyrtec Telephone Pole Ad Campaign: Guerilla or Gorilla Marketing?
• Zyrtec Reminder Print Ad -- Is It Legal?
• What's Behind AstraZeneca's New Push for FDA Preview of DTC Ads?
• Is DTC Bankrupting Pharma?
• Pharma Ad Spending Shrinking!
• Sepracor Not So Keen to Spend Big on DTC for Its Next Product!
• Pharma Marketing ROI: The Emperor Has No Clothes!
• Lunesta Moth Being Mothballed as a Result of Negative Marketing ROI
• Pharma Recession, Part Deux: Online Ad Spending Sinking!
• Pfizer Reneges on DTC Pledge: Afternoon Viagra Ads...
• Jarvik: A Modern DTC Tragedy
• SNL Knows How to Spoof DTC Ads!
• Pfizer Flips. Jarvik Flops!
• User Fees for DTC Ad Review All Over Again
• World Without Broadcast DTC Would be a Boon to eMarketing
• Depression comes from two sources: Real Life and Vytorin
• Jarvik Can't Prescribe and Can't Row a Boat, But Can He Sell?
• Making Fun of Pharma Marketing is Easy
• Crestor Print Ad Touts Plaque Buildup Advantage
• Women Need More Love, Less Drugs
• Jarvik Falters in His Own Defense
• Vytorin and Zetia Are Dead in the Water
• New Vytorin TV Ads Are in the Works - IMHO
• Sleep Aid Drug Print Ad Triptych
• Consumer Reports Rip Rozerem Ad -- A New One!
• FDA Won't be Previewing TV DTC Ads!
• My Cardiologist is on Vacation - "I'm as mad as hell..."
• Look Out for Sexier Cialis Ads -- Maybe Including Beaver!
• Should I Stop Taking Zetia?
• Did Pfizer Run a Chantix "Bookend" Ad During 60 Minutes?
• FDA DTC Payola Out, You Pay In!
• Rozerem Deep Sea Diver Debuts in New Yorker Cartoon Contest
• Jarvik -- Lipitor spokesperson -- "outed" as an unlicensed physician!

Posted in 2007:

• Lunesta's Ad Spending Spree and Other DTC Oddities
• DTC Critters to Strike - Cite New Media Residuals as Issue
• PGAD. EGAD! Another Syndrome/Disorder, Whatever!
• Is Money Being Wasted on Syndrome's Treatment?
• Amitiza DTC Ads Won't Win Any Awards, But...
• AdAge is Wrong! Drug Ads, Not Bad News, Cause Frayed Attention Disorder (FAD)
• RLS Foundation (aka GSK?) Calls for Boycott of Consumer Reports Over Ad Spoof
• AbelsonTaylor's "Your Bowel Movements Miss You" Campaign Pitch for Amitiza
• MM&M Award Winners Announced at Gala NY Event!
• AbelsonTaylor and I are off to the 2007 MM&M Awards Gala Event!
• Another Award for Rozerem! This one...not so good.
• Awards: POE vs. MM&M. I Pick Winners!
• Exubera: A Titanic Failure! What the survivors are saying.
• Exubera Bong Bombs!
• Chantix Californication Dreamin': Viagra II
• Gardasil: Is the Risk of Being "One Less" Worth It?
• Regulating DTC for BTC
• A Pill, a Plan, a Profit? -- Chantix!
• POE: DTC Forevermore
• DTC Here to Stay; Pet Turtles Too!
• Risk-First DTC: A Tactic to Overcome Resistance
• Do Pharma Marketers Need a Thick Skin or Will a Thick Skull Suffice?
• What's Up with the Veramyst "Brief Summary" Print Ad?
• Viva Lovey-Dovey Viagra!
• Cramer-Krasselt Sucks
• FDA at a Mall Near You: The Manchurian Connection
• DTC Tsunami: Duh!
• Rozerem's Cheapskate Sweepstakes Violates Children's Online Privacy Protection Act
• State Sponsored Pharma Ads: It Could Happen!
• Takeda Plots New Rozerem Campaign?
• The Drug Advertising Blame Game
• Why Do DTC Ads - "Viva Viagra" included - Stink?
• Viva Viagra Ad is No Cure for Morte Sales
• Proximity Marketing: From Urinals to Doctors' Offices, Track Your "Target"
• Exubera TV Ad Lacks Bong, er, I mean Bang!
• What do Abe Lincoln, a beaver, and a bong have in common?
• The "RLS Gene" Story: Requip Ad Disguised as News on ABC
• DTC Industry Check-Up or Cherry-Pick?
• alli Marketer Explains "Treatment Effects"
• Marketing's New Maxim: At Least Do No Harm!
• Is Advertising Democratic? Girl from Google Thinks So!
• Google Not Gaga Over SiCKO. Has Remedy for Pharma
• Trade Publications Must Be More than Drug Industry Cheerleaders!
• Rozerem DTC Ads: New Paradigm or Paradox?
• Rozerem Ad Spending Exceeds Sales!
• Alli Newspeak: Oily Spotting is "Treatment Effect"
• Villanova Scientists Prove that DTC Spending Does Not Impact Rx Prices
• PhRMA Report on DTC: Everything's Coming Up Roses!
• GSK's YouTube Disease Awareness Sponsorship
• What is a Marketer's Goal: Legacy or Sales Today!?
• GSK May "Step Into the [DTC] Void" to Defend Avandia
• Alli Ad Campaign Promises Honesty, But Does It Deliver?
• Innerstate: A Correction and Further Criticisms
• The Innerstate DVD. Is TV Next?
• Blogs vs. DTC: What's Best for Consumers?
• Gardasil: Less Hype May Help
• Imagine There's No DTC. I Wonder If You Can.
• Americans Skeptical Of Pharma Cause Marketing
• New Twist to Pharma Chatchke Marketing: the Scrubs Affair
• Device DTC Ad Spend Sinks: Trend or Anomaly?
• Botox BS Piled Higher and Deeper
• Botox Banality Not a Boon for TV Sitcoms
• Celebrex Ad: Let's Dive Deeper
• The New Celebrex TV Ad: What Did You Learn?
• Device DTC: Imagine How Far It Will Go!
• Spend, Spend, Spend Before the End, End, End
• Dead DTC Golden Goose and Other Pharma Fears
• Rozerem Over There? Sic 'em Beav!
• Takeda - Fire These Guys!
• Call for a Rozerem Prescription Boycott!
• Innerstate Private Screening: Philadelphia Style
• Pharma Marketing Sitcoms as Brand Extensions
• Are you happy to see me, or is that just your Exubera Bong?
• eGAD! How I Learned to Stop Worrying and Love Cymbalta!
• Vytorin Ads Are Getting Old -- and Disturbing!
• PhRMA Responds to My Rozerem Ad "Concern"
• Pharma Super Bowl Ads Score Poorly
• Rozerem DTC Emperor (Still) Has No Clothes
• GSK: Don't Go Cold Turkey!
• Tilting Again at the PhRMA Windmill
• Takeda: It Isn't a Reminder Ad --- Wha!!!
• Prilosec OTC Bunco Artists
• Rozerem Reverts to Reminder TV Ads
• PDUFA Payola!
• Lincoln Shot Dead! Beaver Sought for Questioning
• DTC in the New Era

Posted in 2006:
For access to the following posts, please use the Monthly Archive.

• Revamping the Lunesta Ad Campaign
• Disease Mongering Podcast
• DTC Set to Surpass DTPhysician
• Where's DDMAC's Head At?
• Merck on a Roll
• Celebrex Joins the bAdWord Bandwagon!
• Compliance, Math, and Marketers
• Out with the Bad, In with the Good
• Am I Dreaming, or Is This a Rozerem Ad?
• Levitra Levity
• Chantix: Opportunity for Social Marketing Lost?
• Pay Per DTC Ad View Update
• What's In Store from Congress?
• The "Girl from Google"
• Influencing the Dialogue: Marketers Suck at It!
• The Long Road to DTC Excellence
• CommonHealth's Selective Release of DTC Study Data
• Lunesta, Google, and "bAdWords"
• AmbienCR and Lunesta Duke It Out on Web
• Awards: The Good, The Bad, The Ugly
• Rozerem Ads Innovatively Ineffectual
• Allergan Ignores Guidelines, Wins Award Anyway
• Interpretation of Ads: Hokey vs. Horny
• CGC: Old Wine in New Bottles
• Lipitor's Jarvik: Fop or Flop?
• Product Web Sites Not Up to Par
• Marketing 101: Newer is Better
• Print DTC, PhRMA Guidelines, and Balance
• Imprecise DTC Benefit Messages
• Odds & Ends & Interpretations
• Apres IOM, le Deluge!
• IOM Report Calls for DTC Moratorium
• PhRMA's OOA Issues First Report
• (¼±»ý´Ô) Á¤Ç°100%!! ºÒ [Spam DTC Ad]
• Pharma eMarketing in a Slump
• Advertisers Don't Know How DTC Works. Say wha?
• Rozerem Beaver Buzz
• Health Literacy - Words Fail to Tell the Story
• Polypill: Predicted Here First!
• Web DTC Video: Boon or Bane?
• Pay-(FDA)-Per-(Pre)View of DTC
• Caduet, Smaduet! Add some wood to the fire!
• Marketing plan A for Plan B
• Market Research: Privacy Matters
• Levitra Market Research: The Interview
• My Sojourn as Market Research Subject for Levitra
• Precision Buzz Marketing
• WLF: A No-Risk Ad is a Good Ad
• Confusing Creativity with Mission
• Brand Extinction Looms
• Patient Advocacy Marketing: US vs Them
• Anonymous Online Marketing
• Free lunch for patients! Why not?
• Rules of Engagement
• Lunesta, a Sleeping Dog
• PhRMA Intern vs. the Pharma PR Agency!
• DTC Menagerie & Bad Buzz
• Rozerem Ads Dis Lincoln, Show Beaver
• PhRMA Intern vs. BOTOX!
• The Marketing Mix Maze
• DTC, Elections, and PhRMA
• Chantix: PR First, Launch & Ads to Follow
• AMA vs DTC: Spinmeisters at Work
• Fat Acomplia?
• Two Sources of Zocor
• Blockbuster or Ballbuster?
• Medical Device DTC: What's Up With That?
• Restless Brush Syndrome: Lessons for Requip Marketers
• More Reminder Ad Sightings
• DTC Placebo Effect
• Wake Up PhRMA! or Tilting at Windmills
• Pre-emptive Drug Marketing?
• Lunesta: Golden or Bitter Pill?
• FDA Coming to a Mall Near You?
• Sepracor Sneaks In Lunesta Reminder Ad
• Restless Pharma Marketing
• DTC without Risk Revisited
• DTC without the Risk
• Buzz 'n Blogs -- Stealth Marketing
• Immutable Laws of DTC Domain Naming
• Paid Inclusion: Too Hot for Pharma Marketing?
• FDA Backs Down on Coupon Study
• FDA, Coupons, and Sleep Aid DTC Ads
• The End of DTC as We Have Known It
• Finally, Marketing Aligns with PR - Maybe
• Pfizer - the Rodney Dangerfield of the Drug Industry

Posted in 2005:
For access to the following posts, please use the Monthly Archive.

• Pharmaceutical "Tribal Marketing"
• Marketing "Acceptable Risk"
• Less DTC, Better Public Image?
• Why are ED drug sales falling?

• Pfizer Tries Unbranded ED DTC Ads
• AstraZeneca's Risky Proposition
• Why unbranded ads don't work
• FDA DTC Hearings Day 2
• FDA DTC Hearings: Snippets from Day 1

• DTC Regulation: Trick or Treat?
• DTC and Older Americans
• Cut Marketing, Raise Sales!
• Celebrities & Buzz Revisited
• Fake Pharma Advertising

• DTC & Prescribing: Conventional Wisdom Challenged
• Insomnia - the Next DTC Frontier
• FDA May Follow PhRMA's Lead on DTC
• Pfizer No Longer Top 10 Advertiser
• After School Cialis Ads

• Pharma Marketing Newspeak
• Alternative to DTC: cDetailing
• Movies and Drugs: Same Blockbuster Mentality
• Pfizer DTC Pledge: ED is Litmus Test
• Alternatives to DTC, Part 1

• Reminder Ads - Pharma's Dodo?
• PhRMA Finalizes DTC Principles
• Restrict DTC, but Extend the Patent for New Drugs
• Labeling / TV DTC Revisited
• Indication Bloat - The Next DTC Issue

• Deconstructing Frist on DTC
• To Ban or Not to Ban DTC, That is the Question
• DTC - Best of Times, Worst of Times
• WLF Watches FDA Watching Drug Ads
• Future of Drug Print Ads

• New DTC Principles Emerging
• Say it isn't so, J&J!
• eDetailing ROI Better Than DTC?
• You'll Go Blind!
• PEED: A New Viagra Franchise?

• Is Pharmaceutical Marketing BS?
• Pull Back from DTC on TV?
• The Two Bobs: Enzyte vs. Viagra
• Blame the Doc, Not DTC!
• Separation of Church and State

• "Bioshield" Boondoggle
• DTC Straight Talk
• DTC Laissez-faire: A Bankrupt Policy
• It's the land of success!
• he End of DTC as We Know It

• How the FDA Can Fix DTC
• Marketing Drugs Like Packaged Goods at the Super Bowl
• DTC in 2005: Old Dogs, New Tricks?
• Can Drug Ads Communicate Risk?
• Buzz is NOT regulated by FDA